Keen to tell the world about their existence, young biotechnology companies often rush into their own brand of public relations (PR) with little thought—with potentially detrimental consequences.

Simon Walters argues that despite widespread international opposition to China over its human rights record, many will be hoping it wins the trade war with America ...